SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention centers on SELLASs anticipated Phase 3 REGAL topline results for its GPS leukemia treatment, a binary catalyst that has traders weighing hopes for a positive readout against concerns about trial failure. The debate is intensified by sharp price swings, with bullish claims of short pressure and manipulation contested by skeptics who see the outcome as uncertain.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Reported preliminary takeover discussions involving Silver Lake and Saudi Arabias PIF are fueling attention, though traders debate whether the valuation discussed is too low and whether a deal will happen. The speculation comes alongside Unitys strong Q3 results, first GAAP-profitable quarter, and rapid Vector ad growth, which some traders argue support the companys standalone value.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is in focus ahead of the FDAs PDUFA decision on ivonescimab plus chemotherapy for EGFR-mutated lung cancer. Traders are split: bulls point to strong progression-free-survival results, improving survival trends and AstraZenecas backing, while bears emphasize that the trial missed statistical significance for overall survival and the FDA indicated that evidence was needed.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

A sharp, high-volume move has revived speculation about a Big Pharma partnership or buyout for Vikings obesity-drug pipeline, particularly VK2735, alongside attention to its ObesityWeek presentations. Traders disagree on whether the activity signals genuine strategic interest or is another rumor-fueled trading surge; no deal is confirmed.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians persistent share-price weakness and choppy trading dominate discussion, with traders attributing pressure to short-selling or options activityclaims that remain speculative. Bulls point to Q3 progress, R2 recognition and the upcoming Autonomy & AI Day, while skeptics focus on cash burn, profitability and management execution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs abrupt departure has put Nvidias leadership succession in focus, with reports that the board approached Arm CEO Rene Haas and speculation among traders that Huang could return. The community is split between buyers who see Nvidias AI-chip business and upcoming results as resilient and skeptics concerned about succession uncertainty, governance scrutiny, and possible fallout from export investigations.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is under pressure after its outlook raised concerns about delayed third-party data-center capacity and revenue timing, with analyst downgrades and weakness across AI infrastructure stocks adding to the selloff. Traders are divided between expecting further losses and viewing the decline as an overreaction and a buying opportunity.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

A quarterly earnings beat and higher full-year outlook, supported by strong demand for the Wegovy pill, are fueling renewed interest in Novo Nordisk. Bulls see evidence of a recovery, while skeptics point to diabetes weakness, pricing pressure and competition from Eli Lilly as reasons to question whether the turnaround will last.

HawKeye 360, Inc. engages in the provision of defense technology. It offers spectrum monitoring, maritime intelligence, air defence radar monitoring, GNSS interference detection, and communications mapping. Its costumers include a wide range of commercial, government and international entities. The company was founded by Charles T. Clancy, Robert G. McGwier, Chris DeMay and John Serafini in 2015 and is headquartered in Herndon, VA.

HawkEye 360 Inc.

HAWK is drawing attention after reporting record third-quarter revenue and raising its full-year outlook, with traders also highlighting the earnings-call discussion of international growth, cash reserves and lower-cost satellites. The reaction is broadly bullish amid a sharp, high-volume rise, though claims of institutional accumulation remain speculation.

Newsmax Inc. is a holding company, which engages in television broadcasting and multi-platform content publishing that produces original news and editorial content for consumers through various media outlets, including TV new channels, digital and print publications. It operates through the Broadcasting and Digital Segments. The Broadcasting segment produces and licenses news, business news and lifestyle content for distribution through both MVPDs and free OTT streaming platforms. The Digital segment is composed of Newsmax.com and affiliated websites. The company was founded by Christopher Ruddy in 1998 and is headquartered in Boca Raton, FL.

Newsmax Inc. - Ordinary Shares - Class B

Newsmax Inc

Newsmaxs better-than-expected quarterly results and stronger revenue growth are driving the sharp move, with traders focusing on the companys return to profitability and upbeat outlook. The reaction is largely bullish, though some caution that a one-time payment boosted reported results, alongside speculation about a short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Autodesk Shrugs Off Macro Vagaries After Q1 Beat: Analysts, Retail Turn Stick To Bullish Stances

Equity

Following Q1 results, Oppenheimer analysts upped their price target for the Autodesk stock to $350 from $300 and maintained an ‘Outperform’ rating.


Autodesk Says Willing To Review Starboard Slate As Proxy War Heats Up: Retail Mood Worsens

Replying to issues raised by Starboard, Autodesk said it has been taking decisive actions to drive growth, significantly expand operating margin, generate robust cash flow and continue innovating for customers.


Autodesk Activist Drama Unfolds As Starboard Reportedly Gears Up For Proxy Fight: Retail Traders Divided

Starboard is reportedly considering nominating a minority slate of director candidates ahead of Autodesk’s annual shareholders’ meeting.


ProShares Trust - ProShares S&P Kensho Smart Factories ETF

Bullish Sentiment

Autodesk, Inc. (ADSK) stock received a price target boost after the engineering design software maker announced a first-quarter beat.Oppenheimer analysts upped their price target for the Autodesk stock to $350 from $300 and maintained an ‘Outperform’ rating, The Fly reported. The analysts called the results “solid” and expressed comfort at the company reiterating its guidance in a&nbsp;challenging macro/industrial backdrop.The research firm said the company embedded incremental macro conservatism in the guidance even as it flagged no material change in demand through May.Autodesk’s key quarterly metrics for the first quarter of the fiscal year 2026 are as follows:<ul><li>Adj. earnings per share (EPS): $2.29 Vs. $2.15 consensus</li><li>Revenue: $1.63B (up 15% YoY) Vs. $1.61B consensus</li><li>Billings: $1.43B (up 29% YoY)</li></ul>&nbsp;"Q1 was another strong quarter. We have not seen changes in overall business momentum when compared to recent quarters," said Janesh Moorjani, Autodesk CFO.The executive said the guidance for the second quarter and the rest of the fiscal year included currency movements since February, partly offset by additional caution in growth assumptions reflecting greater macroeconomic uncertainty.Autodesk guided second-quarter adjusted EPS and revenue to a range of $2.44-$2.48 and $1.72 billion-$1.73 billion, respectively. Analysts, on average, estimate $2.39 and $1.71 billion, respectively.On Stocktwits, retail sentiment toward Autodesk stock was ‘extremely bullish’ (90/100) by late Thursday, with the message volume at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:618/51;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_23_at_3_51_37_AM_png_9f2ad510f9.webp" alt="Screenshot 2025-05-23 at 3.51.37 AM.png" width="618" height="51"><figcaption>ADSK sentiment and message volume as of 3:52 a.m. ET, May 23 | source: Stocktwits</figcaption></figure>A bullish user said Autodesk had a much better earnings report and forecast&nbsp;than Snowflake, Inc. (SNOW). While noting that Snowflake went up by 13.4% on Thursday, they predicted Autodesk stock&nbsp;would hit&nbsp;$334 on Friday.<stembedurl>https://stocktwits.com/AIIAAIIA_88/message/615613366</stembedurl>Another user feared the guidance could bring the stock down, but expressed faith that it&nbsp;would go up in the long run.<stembedurl>https://stocktwits.com/nj8263/message/615611228</stembedurl><a href="https://stocktwits.com/symbol/ADSK">Autodesk stock </a>rose 3.32% to $304.78 in the after-hours session, but it is down marginally for the year. During the quarter, the company faced a proxy war from activist investor Starboard over the stock's underperformance.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/apple-retail-traders-lose-faith-amid-7-day-losing-streak/ch0Q9ynRbqh">Apple Retail Traders Lose Faith As Market-Cap Trails Microsoft, Nvidia Amid 7-Day Losing Streak</a>

In this photo illustration, the Autodesk Software company logo seen displayed on a smartphone.

Following Q1 results, Oppenheimer analysts upped their price target for the Autodesk stock to $350 from $300 and maintained an ‘Outperform’ rating.

Autodesk Inc.

Pacer Funds Trust - Pacer BlueStar Engineering the Future ETF

ProShares S&P Kensho Smart Factories ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

MAKX News